Potential of heparin and nafamostat combination therapy for COVID-19.

Authors	Hidesaku Asakura, Haruhiko Ogawa
Journal	Journal of thrombosis and haemostasis : JTH (J Thromb Haemost) Vol. 18 Issue 6 Pg. 1521-1522 (06 2020) ISSN: 1538-7836 [Electronic] England
PMID	32302456 (Publication Type: Letter, Comment)
Chemical References	Anticoagulants Benzamidines Guanidines Heparin nafamostat
Topics	Anticoagulants Benzamidines Betacoronavirus COVID-19 Coronavirus Coronavirus Infections Guanidines Heparin Humans Pandemics Pneumonia, Viral SARS-CoV-2

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!